L1CAM and endometrial cancer: In the retrospective analysis conducted by the European Network for Individualised Treatment of Endometrial Cancer Centres, the expression of L1CAM was found in 10% of the 935 stage I endometrioid ECs and was a strong predictor of poor outcome [7].